62088-13-5

Basic information

• Product Name: 3-(3-CYANO-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTER
• Synonyms: ETHYL 3-(3-CYANOPHENYL)-3-OXOPROPANOATE;3-(3-CYANO-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTER;3-(3-Cyanophenyl)-3-oxopropanoic acid ethyl ester;Ethyl (m-cyanobenzoyl)acetate;3-Cyano-b-oxo-benzenepropanoic acid ethyl ester
• CAS NO: 62088-13-5
• Molecular Formula: C₁₂H₁₁NO₃
• Molecular Weight: 217.22
• Mol File: 62088-13-5.mol

Chemical Properties

• Boiling Point: 338 °C at 760 mmHg
• Flash Point: 147.4 °C
• Appearance: /
• Density: 1.19
• Vapor Pressure: 0.000101mmHg at 25°C
• Refractive Index: 1.53
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 9.57±0.46(Predicted)
• CAS DataBase Reference: 3-(3-CYANO-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3-CYANO-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTER(62088-13-5)
• EPA Substance Registry System: 3-(3-CYANO-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTER(62088-13-5)

Safety Data

• Hazardous Substances Data: 62088-13-5(Hazardous Substances Data)

Usage

InChI:InChI=1/C12H11NO3/c1-2-16-12(15)7-11(14)10-5-3-4-9(6-10)8-13/h3-6H,2,7H2,1H3

Upstream product

• 6136-68-1 3-acethylbenzonitrile 
• 105-58-8 Diethyl carbonate 
• 15226-74-1 dicobalt octacarbonyl 
• 6952-59-6 3-cyanobromobenzene 
• 6148-64-7 ethyl potassium malonate 

Downstream Products

• 209732-24-1 ethyl 2-bromo-3-(3-cyanophenyl)-3-oxopropionate 
• 344416-74-6 ethyl 3-(3-cyanophenyl)-1-methyl-1H-pyrazole-4-carboxylate 
• 359424-68-3 3-(5-chloro-isoxazol-3-yl)-benzonitrile 
• 344416-78-0 4-(3-cyano-phenyl)-thiazole-5-carboxylic acid ethyl ester 
• 344416-77-9 4-(3-cyano-phenyl)-2-methyl-thiazole-5-carboxylic acid ethyl ester 
• 344416-76-8 4-(3-cyano-phenyl)-2-methyl-oxazole-5-carboxylic acid ethyl ester 
• 209732-46-7 2-amino-4-(3-cyanophenyl)-5-carboethoxythiazole 
• 209959-47-7 5-(3-cyano-phenyl)-2-methyl-1H-imidazole-4-carboxylic acid ethyl ester 
• 344416-75-7 5-(3-cyano-phenyl)-2-oxo-2,3-dihydro-1H-imidazole-4-carboxylic acid ethyl ester 
• 209959-23-9 3-(3-cyano-phenyl)-1-methyl-1H-pyrazole-4-carboxylic acid (2'-tert-butylsulfamoyl-biphenyl-4-yl)-amide 
• 209731-84-0 4-(3-cyano-phenyl)-2-methyl-thiazole-5-carboxylic acid (2'-tert-butylsulfamoyl-biphenyl-4-yl)-amide 

Relevant articles and documents

One pot direct synthesis of β-ketoesters via carbonylation of aryl halides using cobalt carbonyl

A direct method for the synthesis of β-ketoesters from aryl halides (iodide, bromide) has been described by using cobalt carbonyl as carbon monoxide source in microwave irradiation. Using this protocol, a wide variety of substituted aryl halides has been successfully converted to corresponding β-ketoesters.

DIARYL ETHER DERIVATIVES AS NOTCH SPARING GAMMA SECRETASE INHIBITORS

The invention encompasses a novel class of diaryl ether derivatives which inhibit the processing of APP by the putative ?-secretase while sparing Notch signaling pathway, and thus are useful in the treatment or prevention of Alzheimer's disease without the development of Notch inhibition mediated gastrointestinal issues. Pharmaceutical compositions and methods of use are also included.

CuSO4-catalyzed diazo decomposition in water: a practical synthesis of β-keto esters

CuSO4 was found to be an efficient catalyst for the diazo decomposition of β-hydroxy α-diazoesters in water. 1,2-H shift occurred efficiently to give β-keto esters in high yields. No O-H bond insertion products were identified.

Synthesis and biological activity of 7-phenyl-6,9-dihydro-3H-pyrrolo[3,2-f] quinolin-9-ones: A new class of antimitotic agents devoid of aromatase activity

The newly synthesized 7-phenyl-3H-pyrrolo[3,2-f]quinolinones 16-26 and previously 27 and 28 were assayed for their in vitro antiproliferative activity on tumor cell lines, and the lead compound 16 in vivo on a singenic hepatocellular carcinoma in Balb/c m

OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS

The present application describes oxygen and sulfur containing heteroaromatics and derivatives thereof of formula (I), or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is O or S and D may be C(=NH)NH2, which are useful as inhibitors of factor Xa.

Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core

The selective inhibition of coagulation factor Xa has emerged as an attractive strategy for the discovery of novel antithrombotic agents. Here we describe highly potent benzamidine factor Xa inhibitors based on a vicinally-substituted, heterocyclic core.

Phenyl-isoxazoles as factor XA Inhibitors

The present application describes oxygen and sulfur containing heteroaromatics and derivatives thereof of formula or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is O or S and D may be C(=NH)NH2, which are useful as inhibitors of factor Xa.